BG97122A - Група активно-действащи вещества за възстановителна хемотерапия при вирусни инфекциозни заболявания - Google Patents

Група активно-действащи вещества за възстановителна хемотерапия при вирусни инфекциозни заболявания Download PDF

Info

Publication number
BG97122A
BG97122A BG097122A BG9712292A BG97122A BG 97122 A BG97122 A BG 97122A BG 097122 A BG097122 A BG 097122A BG 9712292 A BG9712292 A BG 9712292A BG 97122 A BG97122 A BG 97122A
Authority
BG
Bulgaria
Prior art keywords
polysaccharide
active substances
group
lрl
plp
Prior art date
Application number
BG097122A
Other languages
English (en)
Other versions
BG61154B1 (bg
Inventor
Chantal Mach
Original Assignee
Chantal Mach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chantal Mach filed Critical Chantal Mach
Publication of BG97122A publication Critical patent/BG97122A/bg
Publication of BG61154B1 publication Critical patent/BG61154B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. Група активно действащи вещества за възстановителна хемотерапия на вирусни инфекциозни заболявания, получена чрез: i/ получаване на обогатени с полизахариди единици на лигнина (рlр) чрез екстрахиране във водна слабо кисела до алкална среда на дървесина или дървесни материали, а също и от (или) растителни клетъчни култури /а/; отделяне на неразтворимите твърди съставни частици; ii/ получаване на нискомолекулни, бедни на полизахариди лигноидни единици (lрl) чрез екстрахиране във водна алкална среда (рн 7-14) на дървесни и естествено овъглени растителни продукти или биоконвертирани дървесни материали /в/; отделяне на неразтворимите в алкална среда твърди съставни частици; iii/ получаване на разтворим във вода реакционен продукт ld(рlр=lрl) с ниско молекулно тегло (ld) от продуктите от фази i и ii чрез взаимодействие на продукта от фаза i на обогатените с полизахариди единици на лигнина (рlр) с продуктите от фаза ii, бедни на полизахариди лигноидни единици (lрl), в условията на водна алкална среда (рн 8-14); изолиране на фракциите lоw dаlтоn на реакционния продукт ld(рlр=lрl) чрез ултрафилтрация при номинални стойности на разреза на деление от около 15 до 45, при което утайката се изхвърля; обработване на разтвора с н+ -катионообменник при рн 3 до 7,0 и по-нататъшно обработване на киселия разтвор на групата активно действащи вещества. 24 претенции, 6 фигури
BG97122A 1990-05-27 1992-11-26 Група активно действащи вещества за възстановителна хемоте- рапия при вирусни инфекциозни заболявания BG61154B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4017091A DE4017091A1 (de) 1990-05-27 1990-05-27 Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten
PCT/DE1991/000450 WO1991018616A1 (de) 1990-05-27 1991-05-27 Molekülverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten

Publications (2)

Publication Number Publication Date
BG97122A true BG97122A (bg) 1993-12-24
BG61154B1 BG61154B1 (bg) 1997-01-31

Family

ID=6407309

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97122A BG61154B1 (bg) 1990-05-27 1992-11-26 Група активно действащи вещества за възстановителна хемоте- рапия при вирусни инфекциозни заболявания

Country Status (17)

Country Link
US (2) US5554596A (bg)
EP (1) EP0535001B1 (bg)
JP (1) JP2905289B2 (bg)
AT (1) ATE110275T1 (bg)
AU (1) AU663684B2 (bg)
BG (1) BG61154B1 (bg)
CA (1) CA2084093C (bg)
DE (2) DE4017091A1 (bg)
DK (1) DK0535001T3 (bg)
ES (1) ES2065034T3 (bg)
FI (1) FI925363A0 (bg)
HU (2) HUT68910A (bg)
NO (1) NO306049B1 (bg)
PL (1) PL168266B1 (bg)
RO (1) RO113430B1 (bg)
RU (1) RU2104016C1 (bg)
WO (1) WO1991018616A1 (bg)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6348503B1 (en) 1996-02-12 2002-02-19 Meryl J. Squires Method and topical treatment composition for herpesvirus hominis
US6350784B1 (en) 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
DE4236346A1 (de) * 1992-10-28 1994-05-05 Chantal Dr Mach Wirkstoffgruppe, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
DE4415087A1 (de) * 1994-04-29 1995-11-09 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische zur Anwendung in der Balneotherapie, Gesundheitspflege und Kosmetik und Verfahren zur Herstellung pharmazeutischer Erzeugnisse sowie Verfahren zu ihrer Anwendung
DE4417254A1 (de) * 1994-05-17 1995-11-23 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische für Tierarzneimittel, Tiergesundheitspflegemittel, Medizinalfuttermittel, Ergotropika und zur Anwendung in der Veterinärhygiene sowie Verfahren zur Herstellung der Mittel und pharmazeutischer Erzeugnisse und Methoden ihrer Anwendung
FR2731162B1 (fr) * 1995-03-01 1997-04-11 Oreal Procede d'extraction d'au moins un actif a partir de cellules vegetales indifferenciees
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
FR2757046B1 (fr) * 1996-12-16 1999-03-05 Dior Christian Parfums Utilisation d'un extrait de resine d'okoume, dans les domaines cosmetique et pharmaceutique, notamment dermatologiques
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
RU2131262C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Способ получения медицинского лигнина
RU2141335C1 (ru) * 1998-12-30 1999-11-20 Общество с ограниченной ответственностью "Лигфарм" Противоопухолевое средство "олипифат" и способ его получения
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
RU2172176C1 (ru) * 2000-06-19 2001-08-20 Общество с ограниченной ответственностью "Нобель" Способ получения противовирусного средства
RU2276157C2 (ru) * 2000-11-27 2006-05-10 Бомсунд Групо Асесор, С.Л. Полисахарид с иммуностимулирующей активностью, способ его получения и применение
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
RU2199335C1 (ru) * 2001-12-21 2003-02-27 Одинец Алексей Глебович Способ повышения эффективности растительных препаратов
RU2233668C1 (ru) * 2003-05-20 2004-08-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Способ получения препарата фенольной природы из растительного сырья
WO2005060352A2 (en) * 2003-12-24 2005-07-07 Ramot At Tel-Aviv University Ltd Antiviral preparations obtained from a natural cinnamon extract
RU2277099C1 (ru) * 2005-02-14 2006-05-27 Институт биологии Коми научного центра Уральского отделения Российской академии наук Способ получения водорастворимого лигнина
RU2401117C1 (ru) * 2009-04-06 2010-10-10 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для профилактики гриппа и острых респираторных заболеваний
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
US20100303935A1 (en) * 2009-05-29 2010-12-02 Squires Meryl J Medicinal Composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185097A (en) * 1978-01-09 1980-01-22 A. H. Robins Company, Inc. Method of combating Herpes simplex viruses with lignosulfonates
JPS54154507A (en) * 1978-05-22 1979-12-05 Eisai Co Ltd Inactivating agents for hbs anitgen
EP0035586B1 (de) * 1980-03-12 1984-06-13 Walter Dr. Dipl.-Phys. Mach Neuer biochemischer Wirkstoff, Verfahren zu seiner Herstellung und diesen Wirkstoff enthaltende pharmazeutische Zubereitung
JPS5939411B2 (ja) * 1980-12-24 1984-09-22 野田食菌工業株式会社 抗動物ウイルス剤
JPS57130919A (en) * 1981-02-06 1982-08-13 Eisai Co Ltd Lignin-containing virucide
DE3206911A1 (de) * 1982-02-26 1983-09-15 Lohmann Tierernährung GmbH, 2190 Cuxhaven Biochemischer wirkstoff, dessen herstellung und diesen wirkstoff enthaltendes mittel
JPS6072823A (ja) * 1983-09-29 1985-04-24 Chisso Corp 抗ウイルス剤
DE3707909A1 (de) * 1987-03-12 1988-09-22 Ruetgerswerke Ag Niedermolekulare alkalihuminate, verfahren zu ihrer herstellung und verwendung
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
US4988799A (en) * 1987-08-11 1991-01-29 Daishowa Chemicals Inc. Lignosulfonate based pharmacologic agent with anti-coagulant and anti-thrombotic activity
JP2602715B2 (ja) * 1988-04-12 1997-04-23 日本製紙 株式会社 抗ウィルス性医薬用組成物
US4935239A (en) * 1988-04-12 1990-06-19 Sanyo-Kokusaku Pulp Co., Ltd. Composition for antiviral medicines
JPH02262524A (ja) * 1989-03-31 1990-10-25 Shozo Toda エイズウイルス増殖抑制剤
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine
JPH02286623A (ja) * 1989-04-27 1990-11-26 Noda Shiyokukin Kogyo Kk 抗ウイルス物質及びその製法
JPH03120223A (ja) * 1989-10-04 1991-05-22 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
JP2923660B2 (ja) * 1990-01-06 1999-07-26 宏 坂上 ウイルス感染防止剤
JP2938916B2 (ja) * 1990-01-10 1999-08-25 日本ケミカルリサーチ株式会社 ヘルペスウィルスの増殖阻害および潜伏感染後の再発阻止剤

Also Published As

Publication number Publication date
PL168266B1 (pl) 1996-01-31
US5554596A (en) 1996-09-10
EP0535001B1 (de) 1994-08-24
US5698524A (en) 1997-12-16
RU2104016C1 (ru) 1998-02-10
NO306049B1 (no) 1999-09-13
AU663684B2 (en) 1995-10-19
CA2084093A1 (en) 1991-11-28
FI925363A7 (fi) 1992-11-25
ES2065034T3 (es) 1995-02-01
AU7892891A (en) 1991-12-31
WO1991018616A1 (de) 1991-12-12
NO924575D0 (no) 1992-11-26
DE59102660D1 (de) 1994-09-29
RO113430B1 (ro) 1998-07-30
ATE110275T1 (de) 1994-09-15
DE4017091A1 (de) 1991-11-28
HU9203747D0 (en) 1993-03-29
HU211541A9 (en) 1995-12-28
JPH05507270A (ja) 1993-10-21
DK0535001T3 (da) 1995-02-20
EP0535001A1 (de) 1993-04-07
JP2905289B2 (ja) 1999-06-14
FI925363A0 (fi) 1992-11-25
HUT68910A (en) 1995-08-28
CA2084093C (en) 2002-10-22
BG61154B1 (bg) 1997-01-31
NO924575L (no) 1993-01-12

Similar Documents

Publication Publication Date Title
DE59102660D1 (de) Molekülverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten.
RU92016546A (ru) Группа активных веществ для восстановительной химиотерапии
KR900007498B1 (ko) 다당류 및 그것을 활성성분으로 함유하는 항바이러스 약제
JPS6429389A (en) Novel physiologically active substance and production thereof
GB8914968D0 (en) Production of virus and purification of viral envelope proteins for vaccine use
GR3025882T3 (en) Said extract bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing
Tangendjaja et al. Isolation of a mimosine degrading enzyme from leucaena leaf
KR900702045A (ko) 천연 hiv gp 160의 제조방법
US20050069989A1 (en) Isoflavone-beta-D-glucan produced by agaricus blazei in the submerged liquid culture and method of producing same
US2372654A (en) Manufacture of substances promoting the growth of yeast and other unicellular plants
CN119285742A (zh) 一种有利于清除人体自由基功能的阿胶肽及其制备方法
Calderone et al. In vitro antiviral effects of an aqueous extract of Artemisia verlotorum Lamotte (Asteraceae)
Sigel et al. In vitro immune responses to viral and tumor antigens in murine breast cancer
CN114344187B (zh) 大叶蛋白菊多肽组合物及其制备方法与应用
JPS59204122A (ja) 人の悪性腫瘍細胞増殖抑制剤の製造方法
Chiba et al. Stabilization of urinary erythropoietin
Halac et al. Changes in composition of ribonucleic acid induced by antigenic stimulation
BG47199A3 (bg) Метод за получаване на желатин
Diderholm Production of interferon by monkey kidney cells infected with simian virus 40
WO1996009832A1 (en) Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
ASTRUP et al. Protein Metabolism of Tissue Cells in vitro
RU2071332C1 (ru) Способ получения препарата, стимулирующего клеточное дыхание
RU2008011C1 (ru) Способ получения средства, обладающего антителостимулирующей, митогенной и интерфферониндуцирующей активностью
US2541676A (en) Thromboplastic preparation
SU1725904A1 (ru) Способ получени бруцеллезной вакцины из штамма 82